Kiplingerยท2025-08-18 20:05Market Overview - Stocks opened cautiously higher but ended mixed, indicating potential volatility throughout the week as Wall Street anticipates clues on rate cuts from the upcoming Fed minutes and Jerome Powell's speech [1][6] - The July jobs report was significantly lower than expected, which has increased expectations for a quarter-point rate cut at the next Fed meeting in September, with some speculating a half-point reduction [2][5] Retail Earnings - Major retailers are set to report earnings this week, providing insights into consumer spending amidst higher tariffs and persistent inflation [7] - Walmart is expected to show strong underlying momentum in its fiscal second-quarter results, with a justified valuation of 38.5 times forward earnings due to significant margin expansion opportunities [8][9] - Target is anticipated to report year-over-year declines in both revenue and earnings, leading to a downgrade by BofA Securities to Underperform, with a lowered price target of $93, indicating over 11% downside potential [10][12] Competitive Landscape - Target faces increasing long-term sales and margin risks due to slowing digital sales growth, competitive threats from Walmart and Amazon, and various pricing pressures [11] - The consensus recommendation for Target among analysts is a Hold, with a mix of ratings reflecting cautious sentiment [12] Pharmaceutical Developments - Novo Nordisk's shares rose 3.7% following the accelerated FDA approval of its obesity drug, Wegovy, for treating a serious liver disease, which may help shift momentum for the company after a challenging start to the year [13][14]